The addition of targeted therapy Avastin (bevacizumab) with chemotherapy can significantly lengthen the lives of women with advanced cervical cancer by close to 30%, according to research presented at the 2013 American Society of Clinical Oncology Congress. The finding is an important discovery in the fight against cervical cancer - the most common cancer in women under the age of 35... via Featured Health News from Medical News Today Read More Here..
No comments:
Post a Comment